Cargando…

Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses

OBJECTIVE: Currently, there are a few biological markers to aid in the diagnosis and treatment of depression. However, it is not sufficient for diagnosis. We attempted to identify differentially expressed proteins during depressive moods as putative diagnostic biomarkers by using quantitative proteo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jiyeong, Joo, Eun-Jeong, Lim, Hee-Joung, Park, Jong-Moon, Lee, Kyu Young, Park, Arum, Seok, AeEun, Lee, HooKeun, Kang, Hee-Gyoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390597/ https://www.ncbi.nlm.nih.gov/pubmed/25866527 http://dx.doi.org/10.4306/pi.2015.12.2.249

Ejemplares similares

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
por: Choi, Hyebin, et al.
Publicado: (2021)

Identification and Validation of SAA4 as a Rheumatoid Arthritis Prescreening Marker by Liquid Chromatography Tandem-mass Spectrometry
por: Seok, AeEun, et al.
Publicado: (2017)

Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
por: Lee, Seungyeon, et al.
Publicado: (2022)

Identification of Transcription Factor YY1 as a Regulator of a Prostate Cancer-Specific Pathway Using Proteomic Analysis
por: Park, Arum, et al.
Publicado: (2017)

Serum Protein Profiling Reveals a Decrease in Apolipoprotein A-IV During a Clinical Depressive Mood State
por: Mun, Sora, et al.
Publicado: (2023)

Spirulina Extract Enhanced a Protective Effect in Type 1 Diabetes by Anti-Apoptosis and Anti-ROS Production
por: Lee, Jiyeong, et al.
Publicado: (2017)

Proteomics-Based Identification of Diagnostic Biomarkers Related to Risk Factors and Pathogenesis of Ischemic Stroke
por: Lee, Jiyeong, et al.
Publicado: (2020)

N-glycoproteomic analysis of human follicular fluid during natural and stimulated cycles in patients undergoing in vitro fertilization
por: Lim, Hee-Joung, et al.
Publicado: (2017)

Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry
por: Mun, Sora, et al.
Publicado: (2019)

Biomarker Discovery of Acute Coronary Syndrome Using Proteomic Approach
por: Shin, Miji, et al.
Publicado: (2021)

Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach
por: Shin, Miji, et al.
Publicado: (2021)

quality of remission in the major depressive disorder
por: Chebli, H., et al.
Publicado: (2023)

Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
por: Lee, Bun-Hee, et al.
Publicado: (2014)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Review of Three-Dimensional Liquid Chromatography Platforms for Bottom-Up Proteomics
por: Duong, Van-An, et al.
Publicado: (2020)

Excess cost of non-remission among outpatients with major depressive disorder
por: Woo, Jong-Min, et al.
Publicado: (2014)

Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders
por: Kim, Ha-Yeon, et al.
Publicado: (2021)

Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial
por: Kim, Mikyung, et al.
Publicado: (2022)

Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial
por: Kim, Mikyung, et al.
Publicado: (2021)

The impact of major depressive disorder on adaptive function: A retrospective observational study
por: Park, Eun-Hee, et al.
Publicado: (2019)

Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Lee, Hyunju, et al.
Publicado: (2021)

The impact of remission and coexisting migraine on anxiety and depression in cluster headache
por: Kim, Byung-Su, et al.
Publicado: (2020)

Development of a Novel Diagnostic Biomarker Set for Rheumatoid Arthritis Using a Proteomics Approach
por: Mun, Sora, et al.
Publicado: (2018)

PS162. Genetic role of CSNK1E on circadian and childhood characteristics of the patients with major depressive disorder
por: Joo, Eun-Jeong, et al.
Publicado: (2016)

The Effect of Cognitive Behavior Therapy-Based Psychotherapy Applied in a Forest Environment on Physiological Changes and Remission of Major Depressive Disorder
por: Kim, Won, et al.
Publicado: (2009)

Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2010)

SUMOylation and Major Depressive Disorder
por: Jeoung, Seok-Won, et al.
Publicado: (2022)

Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases
por: Kwon, Sohyen, et al.
Publicado: (2023)

Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report
por: Park, Young-Min, et al.
Publicado: (2012)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

Cognitive remission: a novel objective for the treatment of major depression?
por: Bortolato, Beatrice, et al.
Publicado: (2016)

Impact of Early-Life Stress and Resilience on Patients with Major Depressive Disorder
por: Seok, Jeong-Ho, et al.
Publicado: (2012)

Electroacupuncture plus moxibustion therapy for patients with major depressive disorder: study protocol for a randomized controlled trial
por: Kim, Mikyung, et al.
Publicado: (2017)

De novo transcriptome profile of coccolithophorid alga Emiliania huxleyi CCMP371 at different calcium concentrations with proteome analysis
por: Nam, Onyou, et al.
Publicado: (2019)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Serum biomarker panel for the diagnosis of rheumatoid arthritis
por: Mun, Sora, et al.
Publicado: (2021)

Assessment of cerebrovascular reactivity during major depression and after remission of disease
por: Vakilian, Alireza, et al.
Publicado: (2010)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle, Romain, et al.
Publicado: (2016)

Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder
por: Korgaonkar, Mayuresh S., et al.
Publicado: (2019)

Validation of the Metabolite Ergothioneine as a Forensic Marker in Bloodstains
por: Lee, Seungyeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n7lf5h0ekpdmijm79h638gqfs9